Company Profile

Yield10 Bioscience Inc (AKA: Metabolix Inc)
Profile last edited on: 6/6/2024      CAGE: 1TLJ3      UEI: MPBJJLNZKV29

Business Identifier: Sustainable, clean solutions for plastics, fuels and chemicals, plastics and chemicals industries
Year Founded
1992
First Award
1993
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

19 Presidential Way
Woburn, MA 01801
   (617) 583-1700
   info@yield10bio.com
   www.yield10bio.com
Location: Multiple
Congr. District: 05
County: Middlesex

Public Profile

Formerly Metabolix Inc, Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : YTEN
IP Holdings
150-249

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 2 USDA $429,421
Project Title: Blow Molded Bioproducts from Renewable Plastics
1996 1 NIH $99,799
Project Title: PHO Biopolymer For Controlled Release
1994 1 NIH $81,000
Project Title: Novel Biopolymers for the Medical Industry
1993 1 AF $70,000
Project Title: Biodegradable Plastic Media Blast Materials
1993 1 NIH $50,000
Project Title: Catalytic antibodies for therapeutic applications

Key People / Management

  Oliver P Peoples -- Co-Founder, President, CEO & Director

  Thomas Auchincloss -- Head of Business Development - New Technologies

  James J Barber -- Former President

  Lynne H Brum -- Vice President, Marketing & Corporate Communications

  Robert Engle -- Vice President Business/Commercial Development & Biopolymers

  Richard P Eno -- Former President

  Joseph Hill -- Chief Financial Officer

  Jay Kouba -- former President

  Raj Krishnaswamy -- Senior Scientist

  Ben Locke -- Director of Government Programs

  Oliver P Peoples -- Chief Scientific Officer

  Max Senechal -- Vice President, Strategy & Commercial Developement

  Anthony J Sinskey -- Founder

  Kristi D Snell -- VP of Research & Chief Science Officer

  Robert L Van Nostrand -- Chairman and Director

  Johan Van Walsem -- Chief Operating Officer

  Johan van Walsem -- COO